TABLE 1.
Details for GEO data.
| GEO | Platform | Strain | Sample | Replicates | group | Treatment | Stage |
| GSE70043 | GPL20586 | NCTC 8325 | Fluc-log | 3 | Treatment | Flucloxacillin | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Fluc-sta | 3 | Treatment | Flucloxacillin | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Vanc-log | 3 | Treatment | Vancomycin | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Vanc-sta | 3 | Treatment | Vancomycin | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Cipro-log | 3 | Treatment | Ciprofloxacin | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Cipro-sta | 3 | Treatment | Ciprofloxacin | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Clind-log | 3 | Treatment | Clindamycin | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Clind-sta | 3 | Treatment | Clindamycin | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Ery-log | 3 | Treatment | Erythromycin | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Ery-sta | 3 | Treatment | Erythromycin | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Line-log | 3 | Treatment | Linezolid | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Line-sta | 3 | Treatment | Linezolid | Stationary |
| GSE70043 | GPL20586 | NCTC 8325 | Con-log | 3 | Control | TSB medium | Logarithmic |
| GSE70043 | GPL20586 | NCTC 8325 | Con-sta | 3 | Control | TSB medium | Stationary |
| GSE56100 | GPL18450 | ATCC29213 | Celecoxib | 2 | Treatment | Celecoxib | Stationary |
| GSE56100 | GPL18450 | ATCC29213 | Con | 2 | Control | TSB medium | Stationary |
GEO, Gene Expression Omnibus; Fluc, flucloxacillin; Vanc, vancomycin; Cipro, ciprofloxacin; Clind, clindamycin; Ery, erythromycin; Line, linezolid; Log, logarithmic phase; Sta, stationary phase.